Skip to main content

MoneyWorks4Me

Aurobindo Pharma submits copy of press release

15 Mar 2016 Evaluate

Aurobindo Pharma has submitted a copy of press release dated March 15, 2016 titled ‘Aurobindo Pharma receives USFDA Approval for Ibandronate Sodium Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1784.55
Dr. Reddys Labs. 1350.30
Cipla 1363.75
Lupin 1987.00
Zydus Lifesciences 1226.75
View more..